Clinical Trial Update: Decitabine as Maintenance Therapy After Standard Therapy in Treating Patients With Previously Untreated Acute Myeloid Leukemia [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating decitabine as maintenance therapy after standard treatment in adults with previously untreated acute myeloid leukemia; results have bee…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Acute Myeloid Leukemia with Cbfb-myh11
• Acute Myeloid Leukemia with Inv Cbfb-myh11
• Acute Myeloid Leukemia with Mllt3-kmt2a
• Acute Myeloid Leukemia with Myelodysplasia-related Changes
• Acute Myeloid Leukemia with Runx1-runx1t1

Drugs mentioned

• Decitabine (Decitabine)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Acute Myeloid Leukemia, Acute Myeloid Leukemia With Myelodysplasia-Related Changes | Phase 2 | Status: COMPLETED | Results posted: 2014-02-20